Literature DB >> 1320876

Activation of TIMP-2/progelatinase A complex by stromelysin.

K Miyazaki1, F Umenishi, K Funahashi, N Koshikawa, H Yasumitsu, M Umeda.   

Abstract

Progelatinase A was purified as a complex with TIMP-2 from the conditioned medium of a human glioblastoma cell line. The TIMP-2/progelatinase complex was resistant to the activation by p-aminophenylmercuric acetic acid (APMA), and showed less than 10% of the activity of the TIMP-2-free active enzyme. When the complex was incubated with stromelysin in the presence of APMA, the 64-kDa progelatinase was effectively converted to the 57-kDa mature enzyme, increasing its gelatinolytic activity about 8-fold. These results suggest that stromelysin is a natural activator of TIMP-2-bound progelatinase A.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320876     DOI: 10.1016/0006-291x(92)91705-u

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  Extracellular matrix degradation by metalloproteinases and central nervous system diseases.

Authors:  A Lukes; S Mun-Bryce; M Lukes; G A Rosenberg
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

2.  The significance of MMP-1 and MMP-2 in peritoneal disseminated metastasis of gastric cancer.

Authors:  K Mizutani; K Kofuji; K Shirouzu
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

3.  Differences in susceptibility of MBP charge isomers to digestion by stromelysin-1 (MMP-3) and release of an immunodominant epitope.

Authors:  Cheryl A D'Souza; Mario A Moscarello
Journal:  Neurochem Res       Date:  2006-07-27       Impact factor: 3.996

4.  Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.

Authors:  D C von Bredow; A E Cress; E W Howard; G T Bowden; R B Nagle
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

5.  Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee joint.

Authors:  C M Flory; P A Pavco; T C Jarvis; M E Lesch; F E Wincott; L Beigelman; S W Hunt; D J Schrier
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

6.  Dysregulation of renal MMP-3 and MMP-7 in canine X-linked Alport syndrome.

Authors:  Velidi H Rao; George E Lees; Clifford E Kashtan; Duane C Delimont; Rakesh Singh; Daniel T Meehan; Gautam Bhattacharya; Brian R Berridge; Dominic Cosgrove
Journal:  Pediatr Nephrol       Date:  2005-03-22       Impact factor: 3.714

7.  Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness.

Authors:  T Etoh; H Inoue; Y Yoshikawa; G F Barnard; S Kitano; M Mori
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

8.  Expression of stromelysin 1 in human astrocytoma cell lines.

Authors:  K Matsuzawa; K Fukuyama; P B Dirks; S Hubbard; M Murakami; L E Becker; J T Rutka
Journal:  J Neurooncol       Date:  1996-12       Impact factor: 4.130

9.  Marked induction of gelatinases, especially type B, in host fibroblasts by human ovarian cancer cells in athymic mice.

Authors:  E Miyagi; H Yasumitsu; F Hirahara; Y Nagashima; H Minaguchi; K Miyazaki; M Umeda
Journal:  Clin Exp Metastasis       Date:  1995-03       Impact factor: 5.150

10.  Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.

Authors:  Y Itoh; S Binner; H Nagase
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.